U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07605247) titled 'Tirzepatide in the Treatment of Endometrial Cancer' on May 18.
Brief Summary: This study is looking for a better way to treat pre-cancer or early-stage cancer in the lining of the uterus in women who are also overweight.
Everyone in the study will receive the standard treatment, a Progesterone IUD (LNG-IUD). This device is put in the uterus and releases hormones to help fight the disease. We will add a new medicine, Tirzepatide, for some people. Tirzepatide is a shot that helps with weight loss and overall health. You will be placed into one of two groups by chance (like flipping a coin):
1. Group 1: You get the Progesterone IUD PL...